Clarus Therapeutics Holdings (CRXT) Annual Balance Sheets

Annual · GAAP · USD millions
Access CRXT quarterly Balance Sheets →
The table below presents a historical view of Clarus Therapeutics Holdings's balance sheet, supporting analysis of financial position trends.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2021)
(Dec 31 2020)
Assets
Cash & cash equivalent26.42
Cash, Cash Equivalents Other0.00
Cash & Short-term Investments26.00
Accounts receivable6.34
Inventories14.21
Prepaid Expense, Current AS4.67
Total Current Assets51.64
Equipment/Property/Plant Net0.07
Total Assets51.71
Liabilities
Accounts Payable, Current AC13.95
Accrued Liabilities, Current AC8.26
Financial Instruments0.00
Notes Payable, Current NO42.27
Other Liabilities, Current0.00
Deferred Revenue DE1.59
Total Current Liabilities66.06
Capital Lease and Other0.00
Long-term Debt Convertible0.00
Total Long-term Debt0.00
Derivative Liability, Noncurrent DE1.57
Accrued Income Taxes, Noncurrent0.00
Total Liabilities67.63
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock305.73
Retained Earnings / Accumulated Deficit-321.66
Other Equity0.00
Common Stockholder's Equity-15.92
Non-controlling interests & other0.00
Total Stockholder's Equity-15.92
Liabilities & Stockholder's Equity51.71
4 historic quarters locked

Sign in to unlock the full Clarus Therapeutics Holdings balance sheet history.

About Clarus Therapeutics Holdings Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-22-224410

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License